Cannabis Rescheduling Could Open a Federal Research Tax Credit

The Dales Report examined legal analysis that broader Schedule III treatment could make the federal research credit available to cannabis companies and urged operators to document qualifying work before any final order. Oklahoma businesses should treat the opportunity as contingent and review project records with tax counsel rather than assume eligibility.